ALK Biomarkers News and reporting on ALK biomarkers. Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer The approval was based on data showing superior efficacy for Alunbrig compared to Pfizer's Xalkori, especially in patients with brain metastasis. Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel The high-throughput S2000 sequencer is the second instrument Genetron Health has received NMPA approval for, following the S5 benchtop instrument last year. Inivata to Employ Liquid Biopsy Test in EORTC Phase II NSCLC Study of Lorlatinib The company will use its InVisionFirst-Lung test to study resistance mutations in patients treated with Pfizer's ALK inhibitor lorlatinib. Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium An IASLC survey showed that molecular testing is not performed in line with expert guidelines, which means only a minority of lung cancer patients are benefitting from precision oncology. IncellDx Inks Chinese Collaboration, Distribution Agreements As part of the agreement, Kindstar will use InCellDx's single-cell immuno-oncology and oncology diagnostic products in China, including Hong Kong and Macao. Jul 18, 2019 Inivata to Test Liquid Biopsy Against Tissue Sequencing in French Prospective Clinical Trial Jun 18, 2019 Next-Generation Sequencing of Pediatric Cancer Patients Could Transform Treatment Paradigms Premium May 16, 2019 Roche Drug Shows Benefit in Pediatric Patients With Rare, Molecularly Defined Tumors Premium Apr 10, 2019 Foundation Medicine, Flatiron Health Publish Clinical Validity of Clinico-Genomics Database Dec 19, 2018 FDA CDx Class Labeling Draft Guidance May Ease Patient Access, Spur Competition Among Test Makers Premium Nov 1, 2018 Almac Developing Next-Generation Sequencing Assay for TP Therapeutics' Anti-Tumor Therapy Premium Oct 31, 2018 Lung Cancer Panel From PlexBio Receives CE Mark Oct 12, 2018 AmoyDx Lung Cancer CDx Approved in South Korea Nov 3, 2017 CMS 14-Day Rule Revisions Ease Precision Medicine Access for Patients, Stakeholders Say Premium Oct 16, 2017 Moffitt Team Uses Proteomic Profiling to ID New Ceritinib Targets in Lung Cancer Premium Sep 14, 2017 New Genetic Variant Discovered to Cause Peritoneal Mesothelioma Sep 7, 2017 Patient Advocacy Strategies Evolve as Genomic Advances Change Understanding of Cancer Aug 17, 2017 Biocept, UT Southwestern Partner for ALK Liquid Biopsy Study Aug 15, 2017 ASCO Updates NSCLC Guidelines With New Directives for Genomic Testing Jun 6, 2017 New Precision Oncology Options Emerge at ASCO in First-Line EGFR-Mutated, ALK-Positive Lung Cancer Premium Jun 1, 2017 Roche ALK Test Gains FDA Approval as CDx for Zykadia May 30, 2017 Novartis' Zykadia Approved for Frontline Treatment of Metastatic, ALK-Positive NSCLC May 15, 2017 HTG Molecular's Q1 Revenues Increase 62 Percent Mar 23, 2017 HTG Molecular Gets CE Mark for Lung Cancer CDx Oct 20, 2016 Moffitt, University of Colorado Teams Identify ALK Inhibitor Sensitizers in Lung Cancer Premium Load More Breaking News BTIG Initiates Coverage of Berkeley Lights With Buy Rating Quest Diagnostics to Offer Biocept's Target Selector NGS Lung Cancer Test Novacyt 2020 Revenues Surge on Strong Demand for SARS-CoV-2 Testing Products Leidos Wins CDC Bioinformatics Contract Worth up to $13M Thermo Fisher Scientific Next-Generation SARS-CoV-2 PCR Test Nabs CE-IVD Mark Cytosine Base Editor Enables Genome-Wide Genetic Function Screening The Scan Renewed Gain-of-Function Worries The New York Times writes that the pandemic is renewing concerns about gain-of-function research. Who's Getting the Patents? A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports. Other Uses CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2. PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.